Details

Autor(en) / Beteiligte

• Sekine, Yuya
• Iwasaki, Yusuke
• Hakozaki, Nozomi
• Endo, Mikiko
• Kamatani, Yoichiro
• Matsuda, Koichi
• Murakami, Yoshinori
• Sano, Takeshi
• Akamatsu, Shusuke
• Kobayashi, Takashi
• Nakagawa, Hidewaki
• Numakura, Kazuyuki
• Narita, Shintaro
• Habuchi, Tomonori
• Momozawa, Yukihide

Titel

Prevalence and risk estimation of cancer-predisposing genes for upper urinary tract urothelial carcinoma in Japanese

Ist Teil von

• Japanese journal of clinical oncology, 2022-12, Vol.52 (12), p.1441-1445

Erscheinungsjahr

2022

Quelle

Oxford Journals 2020 Medicine

Beschreibungen/Notizen

• Abstract Upper urinary tract urothelial carcinoma is a rare cancer that has been associated with mismatch repair genes such as MLH1, MSH2, MSH6 and PMS2. In addition, patients with pathogenic variants of cancer-predisposing genes such as BRCA1 and BRCA2 have been reported. However, how cancer-predisposing genes affect the risk of upper urinary tract urothelial carcinoma in the Japanese population remains unclear. Thus, we performed a case–control sequencing study of 27 cancer-predisposing genes in 208 upper urinary tract urothelial carcinoma patients and 37 727 controls. Only MSH6 and MSH2 were observed with a value of P < 0.05. However, there was no difference in the prevalence of pathogenic variants of BRCA1/2, which does not support the use of a poly adenosine diphosphate-ribose polymerase inhibitor in patients with upper urinary tract urothelial carcinoma. Only mismatch repair genes were associated with patients with upper urinary tract urothelial carcinoma, but the prevalence of pathogenic variants in mismatch repair genes was lower than that reported in previous studies from other populations.